Obesity and drug dosing: acyclovir study seeks better fit
NCT ID NCT02879630
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a special weight-based dose of the antiviral drug acyclovir works properly in people with obesity. Researchers enrolled 13 hospitalized patients (10 obese and 3 non-obese) who were already receiving acyclovir as part of their care. They took blood samples over 12 hours to measure how the drug behaves in the body. The goal is to improve dosing guidelines for obese patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- acyclovir
- What this could lead to
- If successful, this could help doctors find the right acyclovir dose for obese patients, improving treatment safety and effectiveness.
- What could go wrong
- This is a very small study with only 13 participants, so results may not apply to everyone. It only measures drug levels, not actual health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West Virginia University Hospitals
Morgantown, West Virginia, 26506, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?